WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H130138
CAS#: N/A
Description: JQ1-TCO is a clickable BET inhibitor for use as a chemical probe in targeted cancer therapeutics, as well as a method of degrading BRD4. JQT-TCO, which was derived from the BET inhibitor JQ1, was found to lead to a reduction in proliferation, and very similar gene expressions to JQ1. JQ1-TCO was vital in demonstrating the importance of increasing bone marrow penetration in order to increase the efficacy of BET inhibitors.
Hodoodo Cat#: H130138
Name: JQ1-TCO
CAS#: N/A
Chemical Formula: C31H37ClN6O3S
Exact Mass: 608.23
Molecular Weight: 609.190
Elemental Analysis: C, 61.12; H, 6.12; Cl, 5.82; N, 13.80; O, 7.88; S, 5.26
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: JQ1-TCO; JQ1 TCO
IUPAC/Chemical Name: (E)-cyclooct-4-en-1-yl (3-(2-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetamido)propyl)carbamate
InChi Key: CYIPOINYTLBSLB-RQJBGTBZSA-N
InChi Code: InChI=1S/C31H37ClN6O3S/c1-19-20(2)42-30-27(19)28(22-12-14-23(32)15-13-22)35-25(29-37-36-21(3)38(29)30)18-26(39)33-16-9-17-34-31(40)41-24-10-7-5-4-6-8-11-24/h4-5,12-15,24-25H,6-11,16-18H2,1-3H3,(H,33,39)(H,34,40)/b5-4+/t24?,25-/m0/s1
SMILES Code: O=C(OC1CC/C=C/CCC1)NCCCNC(C[C@H]2C3=NN=C(C)N3C4=C(C(C)=C(C)S4)C(C5=CC=C(Cl)C=C5)=N2)=O
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 609.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. A Click-Chemistry Approach Reveals the BET Inhibitor Mechanism of Action. Cancer Discov 1 August 2017; 7 (8): 791. https://doi.org/10.1158/2159-8290.CD-RW2017-120
2. Lebraud H, Wright DJ, Johnson CN, Heightman TD. Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras. ACS Cent Sci. 2016 Dec 28;2(12):927-934. doi: 10.1021/acscentsci.6b00280. Epub 2016 Dec 5. PMID: 28058282; PMCID: PMC5200928.